Skip to main content
OpenTrials

Clinical trial condition

Hemoglobinopathies

Explore clinical trials studying Hemoglobinopathies. Study availability and eligibility vary by location and protocol.

1,050 public trials 170 recruiting studies
Refine in advanced search Browse all conditions

Hemoglobinopathies trial results

Completed

Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)

NCT00171301

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +14 more
Locations
  • Novartis Investigative Site Cairo, Egypt
  • Novartis Investigative Site Beirut, Lebanon
  • Novartis Investigative Site Muscat, Oman
  • Novartis Investigative Site Riyadh, Saudi Arabia
View Trial Details
Completed

Phase 1/2 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HQK-1001 Administered Daily in Patients With Sickle Cell Disease

NCT00842088

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • Trialogic Research Madison, Alabama, United States
  • Children's Hospital and Research Center at Oakland Oakland, California, United States
  • Century Clinical Research, Inc. Daytona Beach, Florida, United States
  • Medical College of Georgia Augusta, Georgia, United States
View Trial Details
Completed

A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia.

NCT00040677

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations
  • Study Site Birmingham, Alabama, United States
  • Study Site Oakland, California, United States
  • Study Site San Francisco, California, United States
  • Study Site Washington D.C., District of Columbia, United States
View all 19 locations
View Trial Details

Related conditions